Yoshihiro Fukumoto Selected Research

Atherosclerotic Plaque (Atheroma)

1/2015	BMP type I receptor inhibition attenuates endothelial dysfunction in mice with chronic kidney disease.
12/2014	Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by 18F-FDG PET/CT.
12/2010	OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization.
10/2004	Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques.
9/2002	Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Fukumoto Research Topics

Disease

21	Heart Failure 04/2024 - 02/2006
21	Pulmonary Hypertension 01/2023 - 12/2006
19	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 08/2011
17	Coronary Artery Disease (Coronary Atherosclerosis) 08/2023 - 02/2006
16	Inflammation (Inflammations) 08/2023 - 09/2002
14	Hypertension (High Blood Pressure) 03/2023 - 07/2003
13	Ischemia 01/2024 - 03/2006
13	Myocardial Infarction 01/2023 - 05/2003
13	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 09/2004
12	Atherosclerosis 05/2024 - 03/2008
12	Pulmonary Arterial Hypertension 03/2023 - 02/2007
10	Hypoxia (Hypoxemia) 05/2024 - 12/2006
9	Neoplasms (Cancer) 06/2023 - 01/2014
8	Insulin Resistance 04/2021 - 10/2014
6	Aortic Dissection 09/2023 - 10/2017
6	Fibrosis (Cirrhosis) 01/2022 - 03/2008
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2024 - 01/2020
5	Glucose Intolerance 01/2022 - 06/2012
5	Stroke (Strokes) 01/2021 - 09/2010
5	Reperfusion Injury 01/2020 - 03/2006
5	Atherosclerotic Plaque (Atheroma) 01/2015 - 09/2002
5	Arteriosclerosis 01/2013 - 01/2004
5	Infarction (Infarctions) 01/2012 - 03/2006
5	Shock 10/2011 - 02/2008
4	Chest Pain (Chest Pains) 01/2023 - 10/2004
4	Hemorrhage 01/2023 - 02/2006
4	Chronic Renal Insufficiency 01/2023 - 01/2015
4	Chronic Limb-Threatening Ischemia 11/2022 - 01/2019
4	Pathologic Constriction (Stenosis) 07/2021 - 10/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2013
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019 - 01/2014
4	Hypertrophy 06/2014 - 03/2008
3	Essential Hypertension 08/2023 - 01/2016
3	Cardiomyopathies (Cardiomyopathy) 01/2023 - 01/2013
3	Angina Pectoris 01/2023 - 11/2005
3	Ventricular Tachycardia 10/2022 - 02/2006
3	Hyperuricemia 04/2022 - 01/2021
3	Frailty 12/2021 - 02/2021
3	Cognitive Dysfunction 12/2021 - 01/2017
3	Thrombosis (Thrombus) 04/2020 - 02/2008
3	Body Weight (Weight, Body) 01/2019 - 12/2007
3	Abdominal Aortic Aneurysm 03/2018 - 01/2017
3	Muscle Spasticity (Spastic) 12/2017 - 09/2004
3	Acute Coronary Syndrome 10/2017 - 10/2004
3	Hip Osteoarthritis (Coxarthrosis) 06/2017 - 01/2012
3	Vascular Remodeling 01/2015 - 04/2007
3	Right Ventricular Hypertrophy 06/2014 - 12/2006
3	Ventricular Remodeling 01/2014 - 08/2010
2	Cardiogenic Shock 05/2024 - 09/2023
2	Heart Arrest (Cardiac Arrest) 05/2024 - 08/2013
2	Rupture 09/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

22	rho-Associated KinasesIBA 06/2014 - 01/2004
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2023 - 06/2007
11	fasudil (AT 877)IBA 01/2014 - 01/2004
10	LipidsIBA 08/2023 - 09/2002
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
8	Vasodilator Agents (Vasodilators)IBA 03/2023 - 09/2004
7	pitavastatin (itavastatin)FDA Link 08/2023 - 01/2018
6	LDL CholesterolIBA 08/2023 - 12/2014
6	MonocrotalineIBA 01/2014 - 12/2006
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2023 - 10/2004
5	C-Reactive ProteinIBA 02/2021 - 07/2003
5	Angiotensin IIIBA 01/2020 - 02/2009
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 06/2014
4	CalciumIBA 09/2023 - 10/2004
4	oxidized low density lipoproteinIBA 08/2023 - 09/2002
4	Antihypertensive Agents (Antihypertensives)IBA 08/2023 - 01/2016
4	Amlodipine (Norvasc)FDA LinkGeneric 08/2023 - 03/2008
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 09/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2014
4	CollagenIBA 01/2014 - 01/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 03/2007
3	SaltsIBA 01/2023 - 01/2020
3	omega-Chloroacetophenone (Mace)IBA 01/2023 - 09/2010
3	Febuxostat FDA Link 04/2022 - 01/2021
3	HDL CholesterolIBA 01/2022 - 05/2015
3	AlbuminsIBA 12/2021 - 01/2016
3	Prasugrel Hydrochloride FDA Link 06/2021 - 10/2017
3	Clopidogrel (Plavix)FDA Link 06/2021 - 10/2017
3	Triglycerides (Triacylglycerol)IBA 04/2021 - 05/2015
3	Insulin (Novolin)FDA Link 12/2020 - 01/2019
3	Advanced Glycation End ProductsIBA 01/2020 - 01/2019
3	CytokinesIBA 01/2020 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2014
3	Indicators and Reagents (Reagents)IBA 01/2011 - 12/2007
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2009 - 11/2005
3	Monomeric GTP-Binding ProteinsIBA 08/2007 - 01/2004
2	Heparin (Liquaemin)FDA LinkGeneric 04/2024 - 07/2023

Therapy/Procedure

39	Therapeutics 04/2024 - 09/2004
9	Percutaneous Coronary Intervention 01/2022 - 02/2006
7	Stents 01/2023 - 01/2004
5	Resistance Training 01/2023 - 01/2014
5	Extracorporeal Shockwave Therapy 08/2010 - 02/2006
4	Palliative Care (Palliative Therapy) 01/2022 - 01/2020
3	Defibrillators (Defibrillator) 05/2023 - 03/2021
3	Exercise Therapy (Therapy, Exercise) 01/2023 - 05/2015
3	Surgical Amputation (Amputations) 11/2022 - 01/2019
3	Endarterectomy (Thromboendarterectomy) 11/2017 - 01/2014
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2011 - 09/2004
2	Extracorporeal Membrane Oxygenation 05/2024 - 09/2023